These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 650059)

  • 1. Carbamylation distributions in extracorporeal treatment of sickle cell anemia.
    Uvelli DA; Agodoa LC; Babb AL
    J Lab Clin Med; 1978 Jun; 91(6):939-47. PubMed ID: 650059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies of a continuous extracorporeal cyanate treatment system for patients with sickle cell disease.
    Lee MY; Uvelli DA; Agodoa LC; Scribner BH; Finch CA; Babb AL
    J Lab Clin Med; 1982 Sep; 100(3):334-44. PubMed ID: 7108348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.
    Deiderich DA; Trueworthy RC; Gill P; Cader AM; Larsen WE
    J Clin Invest; 1976 Sep; 58(3):642-53. PubMed ID: 956392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia.
    Balcerzak SP; Grever MR; Sing DE; Bishop JN; Segal ML
    J Lab Clin Med; 1982 Sep; 100(3):345-55. PubMed ID: 7108349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
    Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
    J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
    Castro O; Orlin J; Finch SC
    Yale J Biol Med; 1974 Mar; 47(1):55-60. PubMed ID: 4825087
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT; Rodgers GP; Schechter AN
    Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (second of three parts).
    Dean J; Schechter AN
    N Engl J Med; 1978 Oct; 299(15):804-11. PubMed ID: 692564
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia.
    De Furia FG; Miller DR; Cerami A; Manning JM
    J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas chromatographic determination of the carbamylation of hemoglobin S by cyanate.
    Manning JM; Lee CK; Cerami A; Gillette PN
    J Lab Clin Med; 1973 Jun; 81(6):941-5. PubMed ID: 4710373
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extracorporeal system that modifies hemoglobin in patients with sickle cell anemia.
    Babb AL; Scribner BH; Uvelli DA; Fry DL; Agodoa LC
    Artif Organs; 1979 Feb; 3(1):62-72. PubMed ID: 435126
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of the carbamylation kinetics and antisickling mechanism in hemoglobin S blood.
    Uvelli DA; Lee MY; Manning JM; Hlastala MP; Babb AL
    J Lab Clin Med; 1980 May; 95(5):748-58. PubMed ID: 7365317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life span of carbamylated red cells in sickle cell anemia.
    Milner PF; Charache S
    J Clin Invest; 1973 Dec; 52(12):3161-71. PubMed ID: 4750447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
    Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
    Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of the blood concentrations of cyanate after intravenous administration to patients with sickle-cell disease.
    Nigen AM; Peterson CM; Gillette PN; Manning JM
    J Lab Clin Med; 1974 Jan; 83(1):139-46. PubMed ID: 4808651
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
    Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
    Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the cyanate-hemoglobin reaction in whole blood.
    Uvelli DA; Fry DL; Finch CA; Babb AL
    J Lab Clin Med; 1977 May; 89(5):978-86. PubMed ID: 16070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of reactions within single erythrocytes: studies by microspectrophotometry.
    Antonini E; Brunori M; Giardina B; Benedetti PA; Grassi S; Gualtieri P
    Haematologia (Budap); 1982; 15(1):3-15. PubMed ID: 7117941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.